• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$40.88 $1.34 (3.39%)

REAL-TIME: Last trade at

Par Pharmaceutical Companies, ...

NYSE:PRX

Jump to this page for:

Related Resources

Par Pharmaceuticals Companies, Inc. - Value

5/15/2012 by Nasdaq

Top Analyst Upgrades & Downgrades

5/15/2012 by 247wallst

Par Pharma Beats on All Fronts - Analyst Blog

5/9/2012 by Nasdaq

Par Pharmaceutical Beats on Both Top and Bottom Lines

5/8/2012 by DailyFinance

Par Pharma Acquires Handa's ANDA - Analyst Blog

4/20/2012 by Nasdaq

Par Pharma Launches Generic Provigil - Analyst Blog

4/11/2012 by Nasdaq

US Court Rules For AstraZeneca's Seroquel XR Patent

3/29/2012 by Smart Money

PRX Outperforms; Reaffirms Guidance - Analyst Blog

3/5/2012 by Nasdaq

Par Pharmaceutical Outruns Estimates Again

3/2/2012 by DailyFinance

Par Pharma Absorbs Edict Pharma - Analyst Blog

2/22/2012 by Nasdaq

Get These 5 Stocks While They're Hot - Investment Ideas

1/27/2012 by Nasdaq

Lawsuit Alleges Walgreen, Par Pharma Overcharged For Generics

1/13/2012 by Smart Money

Pozen Inks $75 Million Royalty Deal for Treximet

11/26/2011 by DailyFinance

Why Par Pharmaceutical May Be About to Take Off

10/31/2011 by DailyFinance

Par Pharmaceutical Earnings Preview

10/31/2011 by DailyFinance

FDA OKs Generics Of Zyprexa For Bipolar Disorder, Schizoprenia

10/24/2011 by Smart Money

Mid-Day Update: Stocks Shift Higher After Mixed Start; China, Earnings Weigh

10/18/2011 by Nasdaq

Stocks Rebound, Trade Higher Amid Mixed Slate of Earnings; China Data Weighs

10/18/2011 by Nasdaq

Will AstraZeneca Disappoint Analysts Next Quarter?

8/18/2011 by DailyFinance

Generics on the Rise: A Big Threat to Big Pharma?

8/10/2011 by Nasdaq

Somaxon Discloses Patent-Infringement Suit Against Mylan

6/28/2011 by Smart Money

Somaxon Files Lawsuit Against Par Pharma Involving Generic Silenor

5/27/2011 by Smart Money

UPDATE: Novartis CEO Warns On Misconduct After Executive Firings

5/10/2011 by Smart Money

Top Pharma Stocks That Hedge Funds Love

4/21/2011 by Seeking Alpha

Pozen: Injunction Stops Par From Selling Generic Of Pozen Drug

4/15/2011 by Smart Money

32 Mid Caps With Sales and EPS Declining in 2012

4/12/2011 by Seeking Alpha

GlaxoSmithKline: Pronova Reaches Agreement With Apotex

3/30/2011 by Smart Money

Glaxo Partner Provova Strikes Lovaza Court Deal With Apotex

3/30/2011 by Smart Money

14 Highly Profitable, Low P/E Laggards Worth a Look

3/27/2011 by Seeking Alpha

6 Underperforming Stocks That Consistently Beat Analyst Earnings Estimates

3/10/2011 by Seeking Alpha

30 Oversold Stocks Being Snapped Up by Mutual Funds

3/2/2011 by Seeking Alpha

The Best in Generic Drug Company Stocks

2/13/2011 by Seeking Alpha

Intellipharmaceutics: Emerging Biotech Primed With Upcoming Catalysts

1/21/2011 by Seeking Alpha

Analyst Calls: BBT, CI, DG, DHI, HSY, NFLX, RAI, TOL, UNH, WAT, XOM ...

1/6/2011 by BloggingStocks

INTERVIEW: Glaxo's Omega-3 Partner Pronova Unfazed By Rivals

12/6/2010 by Smart Money

PAR Pharmaceutical: A Quality Discount Generic Pharma Play

11/1/2010 by Seeking Alpha

Stocks That Would Benefit From the Legalization of Marijuana

10/31/2010 by Seeking Alpha

Analyst Calls: ABC, BBY, CF, CSIQ, ERIC, MO, N, NAV, ORLY, PCAR, RCRC, SYY ...

9/30/2010 by BloggingStocks

Par Pharma Unit:FDA Approves Zuplenz As Soluble-Film Medicine

7/2/2010 by Smart Money

Par Pharma CFO Steps Down

6/4/2010 by Fox Business
See More Articles...